bioRxivBiophysics
Mechanism of the Covalent Inhibition of Human Transmembrane Protease Serine 2 as an Original Antiviral Strategy
A. Spinello, L. D'Anna, E. Bignon, T. Miclot, S. Grandemange, A. Terenzi, G. Barone, F. Barbault, A. MONARI
Abstract
The Transmembrane Protease Serine 2 (TMPRSS2) is a human enzyme which is involved in the maturation and post-translation of different proteins. In addition of being overexpressed in cancer cells, TMPRSS2 plays a further fundamental role in favoring viral infections by allowing the fusion of the virus envelope and the cellular membrane, notably in SARS-CoV-2. In this contribution we resort to multiscale molecular modeling to unravel the structural and dynamical features of TMPRSS2 and its interaction with a model lipid bilayer. Furthermore, we shed light into the mechanism of action of a potential inhibitor (Nafamostat), determining the free-energy profile associated with the inhibition reaction, and showing the facile poisoning of the enzyme. Our study, while providing the first atomistically resolved mechanism of TMPRSS2 inhibition, is also fundamental in furnishing a solid framework for further rational design targeting transmembrane proteases in a host-directed antiviral strategy. TOC GRAPHICS O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=193 SRC="FIGDIR/small/537985v1_ufig1.gif" ALT="Figure 1"> View larger version (108K): org.highwire.dtl.DTLVardef@19dd8c9org.highwire.dtl.DTLVardef@394c0org.highwire.dtl.DTLVardef@11ad383org.highwire.dtl.DTLVardef@347a8c_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: protein structure
- research focus: protein folding & dynamics
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structure, activity and inhibition of human TMPRSS2, a protease implicated in SARS-CoV-2 activation
B. J. Fraser, S. Beldar, … F. Benard·bioRxiv·Jun 23, 2021
- Molecular mechanism of SARS-CoV-2 cell entry inhibition via TMPRSS2 by Camostat and Nafamostat mesylate
T. Hempel, L. Raich, … F. Noe·Chemical SciencePeer-reviewed·Jan 1, 2021
- Molecular docking between human TMPRSS2 and the serine protease Kunitz-type inhibitor rBmTI-A
L. d. M. Bomediano-Camillo, S. D. Sasaki·bioRxiv·Mar 13, 2022
- Structural basis of TMPRSS11D specificity and autocleavage activation
Bryan J. Fraser, Ryan P. Wilson, … C.H. Arrowsmith·Nature CommunicationsPeer-reviewed·May 10, 2025
- Discovery of TMPRSS2 inhibitors from virtual screening
Xin Hu, Jonathan H. Shrimp, … Min Shen·bioRxiv·Dec 28, 2020
- Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by the N-terminal peptide of lactoferrin
A. Ohradanova-Repic, L. Gebetsberger, … V. Leksa·bioRxiv·Dec 20, 2021